Operating Segments (Tables)

6 Months Ended

Mar. 31, 2014

Segment Reporting [Abstract]

Segment Revenue, Operating Income and Depreciation and Amortization

The tables below present segment revenue, operating income and depreciation and amortization, as follows:

	Three months ended March 31,						Six months ended March 31,
(Dollars in thousands)	2014			2013			2014			2013
Revenue:
Medical Device	$	10,482		$	9,735		$	21,031		$	20,266
In Vitro Diagnostics		3,122			3,960			6,456			7,280
Total revenue	$	13,604		$	13,695		$	27,487		$	27,546
Operating income:
Medical Device	$	5,282		$	4,785		$	10,610		$	10,625
In Vitro Diagnostics		633			1,267			1,303			2,018
Total segment operating income		5,915			6,052			11,913			12,643
Corporate		(2,435	)		(1,923	)		(4,104	)		(3,637	)
Total operating income	$	3,480		$	4,129		$	7,809		$	9,006
Depreciation and amortization:
Medical Device	$	287		$	311		$	581		$	628
In Vitro Diagnostics		213			218			427			433
Corporate		184			195			372			385
Total depreciation and amortization	$	684		$	724		$	1,380		$	1,446